Related Experiment Video
Updated: Jun 29, 2025
05:52
Author Spotlight: Efficient Retinal Ganglion Cell Counting in Mouse Models of Glaucoma for Treatment Evaluation
Published on: October 4, 2024
959
Optimizing retinal ganglion cell nuclear staining for automated cell counting
Fangyu Lin1, Su-Ting Lin1, Jiaxing Wang1
1Department of Ophthalmology, Emory University, 1365B Clifton Road NE, Atlanta, GA, 30322, USA.
Experimental Eye Research
|March 30, 2024
Summary
Accurate counting of retinal ganglion cells (RGCs) is vital for glaucoma research. Combining Brn3a and POU6F2 nuclear markers labels all RGC subtypes in mice, enabling precise automated cell quantification.
Area of Science:
- Neuroscience
- Ophthalmology
- Cell Biology
Background:
- Retinal ganglion cells (RGCs) are crucial for visual information transmission.
- Diseases like glaucoma severely impact RGCs, necessitating accurate quantification in research.
- Existing pan-RGC markers (RBPMS, THY1) and nuclear markers (Brn3a) have limitations for comprehensive RGC counting.
Purpose of the Study:
- To develop a reliable method for labeling all RGC nuclei in mouse retinas for accurate automated counting.
- To overcome the limitations of current markers in identifying all RGC subtypes.
Main Methods:
- Investigated POU6F2 as a nuclear marker for RGC subtypes.
- Tested a combined antibody staining approach using Brn3a and POU6F2.
- Validated the combined staining against the established pan-RGC marker RBPMS.
Main Results:
- POU6F2 labels RGC subtypes not identified by Brn3a.
- Combined Brn3a and POU6F2 antibodies successfully label all RGC nuclei in mouse retinas.
- All RBPMS-labeled RGCs were also positive for either Brn3a or POU6F2.
Conclusions:
- The combination of Brn3a and POU6F2 antibodies provides a comprehensive pan-RGC nuclear stain.
- This novel staining method enables accurate automated quantification of RGCs in mouse models.
- Facilitates improved research into RGC-affecting diseases like glaucoma.
